SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Versicor (VERS)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Arthur Radley who wrote (40)3/17/2003 11:22:30 PM
From: JOEBT1  Read Replies (1) of 83
 
Texas Dude--Thank you. I listened to the conference call and they said the same thing as the Dietz comments. In the call they said that the recurrence difference was irrelevant since they would maintain treatment in the real world as compared to the trial. I suspect it will be down somewhat even though the news is as good as could be expected. The analysts seem to be satisfied with the answers given during the conference call.
Joe
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News